Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.

ConditionPulpitis - Irreversible

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age4-9

SponsorMohamed Nashaat Mohamed

About this trial

itle: Evaluation of Pulpotomy using Neoputty MTA vs. Pulpectomy using Metapex in Children (4-9 years).

Objective: Compare clinical and radiographic success of pulpotomy vs. pulpectomy for vital primary molars with irreversible pulpitis.

Design: Randomized controlled trial with 2-arm parallel groups.

Participants: Healthy children aged 4-9 with specific inclusion/exclusion criteria.

Outcomes: Primary (pain relief, absence of complications) and secondary (radiographic success).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1. Symptoms typical of irreversible pulpitis, such as spontaneous, unprovoked pain lasting from a few seconds to several hours prior to the dental visit, or pain exacerbated by hot and/or cold stimuli that lingers even after the stimuli are removed.

Disqualifiers

1. Clinical signs of pulpal infection, such as pathologic tooth mobility, parulis/fistula, or soft tissue swelling.

Trial design

Design model

Parallel

Treatments tested in this trial

Pulpotomy using Neoputty Mineral Trioxide Aggregate
Procedure/Surgery
Pulpotomy (Test Group): Removal of coronal pulp followed by Neoputty MTA placement and restoration.
single visit pulpectomy using metapex
Procedure/Surgery
pulpectomy: removal of radicular pulp followed by metapex placement and final restoration

Treatment groups

70 Participants

are divided into 2 treatment groups

Group A: PulpotomyExperimental treatment 1 intervention

Group B: pulpectomyActive comparator 1 intervention

Trial outcomes